Scarica l'app Stockscreener
59.82
1.10%
0.65
Dopo l'orario di chiusura:
59.82
Bright Minds Biosciences Inc Borsa (DRUG) Ultime notizie
Bright Minds Biosciences (DRUG) Slides 1% as Buyers and Sellers Battle Near Critical LevelsBull Flag - newsline.com
Behavioral Patterns of DRUG and Institutional Flows - Stock Traders Daily
Bright Minds Biosciences (DRUG) Surges 3.86% as Shares Test Key Resistance ZoneMomentum Trade - newsline.com
News Releases for Bright Minds Biosciences Inc. - The Canadian Securities Exchange (CSE)
Bright Minds Biosciences Sets March 31, 2026 AGM, Files Meeting Materials on Form 6-K - TipRanks
Bright Minds Biosciences (NASDAQ: DRUG) details 2026 AGM, board nominees and auditor - Stock Titan
H.C. Wainwright reiterates Bright Minds stock rating on epilepsy data - Investing.com UK
Bright Minds Biosciences Sets March 31, 2026 Date for Annual General Meeting - TipRanks
Bright Minds (DRUG) outlines 2026 AGM in Vancouver with key record dates - Stock Titan
H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $145 - Moomoo
H.C. Wainwright reiterates Bright Minds stock rating on epilepsy data By Investing.com - Investing.com South Africa
DRUG Reiterated by HC Wainwright & Co. -- Price Target Maintained at $145 - GuruFocus
(DRUG) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Bright Minds Biosciences to Present at Jefferies Healthcare Conference and Grants New Stock Options - TipRanks
Bright Minds Biosciences (NASDAQ: DRUG) grants 109,000 options and sets June 3 Jefferies talk - Stock Titan
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference - Weekly Voice
Bright Minds, a biotech targeting epilepsy, to speak at Jefferies health event - Stock Titan
Bright Minds Biosciences (DRUG) Edges Higher Amid Consolidation Near Key Support LevelLiquidity Order Flow - newsline.com
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - AOL.com
B Group Discloses New Position in Bright Minds Biosciences - HarianBasis.co
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - The Motley Fool
Bright Minds Biosciences Stock Jumps After $220 Piper Sandler Call—What DRUG Traders Are Watching - Bez Kabli
Piper Sandler raises Bright Minds stock price target on program progress - Investing.com UK
Piper Sandler Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Raises Target Price to $220 - Moomoo
Piper Sandler raises Bright Minds stock price target on program progress By Investing.com - Investing.com South Africa
Bright Minds Biosciences Boosts Cash Reserves as R&D Losses Widen in Q2 2026 Filing - TipRanks
[6-K] BRIGHT MINDS BIOSCIENCES INC. Current Report (Foreign Issuer) | DRUG SEC FilingForm 6-K - Stock Titan
Vestal Point (DRUG) and Ryan Wilder report 492,319 shares, 5% stake - Stock Titan
Janus Henderson (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
Janus Henderson Group (DRUG) discloses 1.28M shares, 13.1% stake - Stock Titan
Bright Minds Biosciences Inc. (DRUG) Eps Diluted (TTM) - Zacks Investment Research
Vivo entities disclose 504,645 shares in Bright Minds Biosciences (DRUG) - Stock Titan
TradingKey - TradingKey
Bright Minds Biosciences Inc expected to post a loss of C$1.19 a shareEarnings Preview - TradingView
Bright Minds Biosciences (DRUG) to Release Earnings on Friday - MarketBeat
Trading Systems Reacting to (DRUG) Volatility - Stock Traders Daily
This Insider Has Just Sold Shares In Bright Minds Biosciences - simplywall.st
DRUG SEC FilingsBright Minds Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Cormorant sells $9.78m in Bright Minds Biosciences stock - Investing.com UK
Cormorant sells $9.78m in Bright Minds Biosciences stock By Investing.com - Investing.com Australia
[SCHEDULE 13G/A] BRIGHT MINDS BIOSCIENCES INC. Amended Passive Investment Disclosure - Stock Titan
Insider Selling: Bright Minds Biosciences (NASDAQ:DRUG) Major Shareholder Sells 109,331 Shares of Stock - MarketBeat
Bright Minds Biosciences(DRUG.US) Insider Sells US$9.79 Million in Common Stock - Moomoo
Bright Minds Biosciences (DRUG) holder sells 109,331 shares in open market - Stock Titan
Bright Minds announces ATM offering up to $100 million - MSN
1.27%
1.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):